• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Nonsteroidal Anti-Inflammatory Drug exposure associated with development of microscopic colitis

byKeerthana PasumarthiandAlex Chan
August 10, 2022
in Chronic Disease, Gastroenterology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) were independently associated with the development of microscopic colitis.

Evidence Rating Level: 2 (Good)

Microscopic colitis, a type of chronic inflammatory bowel disease, is a common cause of abdominal pain and chronic diarrhea. In recent years, the incidence of microscopic colitis has significantly increased to levels comparable to Crohn’s disease and ulcerative colitis. It has been suggested that medications such as non-steroidal anti-inflammatory drugs (NSAIDs), proton-pump inhibitors (PPIs), and selective serotonin reuptake inhibitors (SSRIs) can contribute to the onset of microscopic colitis; however, the evidence behind this remains unclear. In this prospective cohort study, 144 patients prospectively evaluated for chronic diarrhea underwent colonoscopic evaluation and were assessed for their medication use and evidence of microscopic colitis on colonoscopy, in attempt to investigate the potential association between drug exposure and microscopic colitis. From these included patients, microscopic colitis was identified in a total of 80 individuals. Of these patients diagnosed, the use of aspirin and other NSAIDs was higher compared to those that were not diagnosed with microscopic colitis (OR 3.04, 95%CI 1.65-5.69). In conclusion, this study confirms that the use of NSAIDs is likely associated with the onset of microscopic colitis. Strengths of this study include its prospective design and use of a control group who had a similar presentation. However, this study remains limited due to its single center patient enrollment reducing generalizability to the broader population. As well, medication use data was obtained from patients through surveys, which may be not entirely accurate. Despite this, further research investigating medication use and its effect on the development of microscopic colitis should be conducted, considering the findings of this study.

Click to read the study in BMC Gastroenterology

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Oral vancomycin may be effective for pouchitis in inflammatory bowel disease

Structured exercise intervention improves survival in colon cancer patients

Fecal calprotectin is a useful marker for defining small bowel endoscopic remission in Crohn’s disease

Tags: ColitisGastroenterologynsaids
Previous Post

Breast MRI most sensitive screening modality in high-risk patients [Classics Series]

Next Post

#VisualAbstract: Dapagliflozin associated with reduced risk of cardiovascular and kidney outcomes irrespective of background use of cardiovascular medications

RelatedReports

Biosimilar to infliximab shows equivalent safety and efficacy for treating Crohn’s disease
Chronic Disease

Oral vancomycin may be effective for pouchitis in inflammatory bowel disease

July 10, 2025
Development of a risk index for colorectal cancer screening
Gastroenterology

Structured exercise intervention improves survival in colon cancer patients

July 9, 2025
Biosimilar to infliximab shows equivalent safety and efficacy for treating Crohn’s disease
Chronic Disease

Fecal calprotectin is a useful marker for defining small bowel endoscopic remission in Crohn’s disease

July 7, 2025
Provision of medically-tailored meals linked with lower admissions and medical spending
Chronic Disease

Time-restricted eating does not confer changes in sleep, mood, or quality of life

July 4, 2025
Next Post
#VisualAbstract: Dapagliflozin associated with reduced risk of cardiovascular and kidney outcomes irrespective of background use of cardiovascular medications

#VisualAbstract: Dapagliflozin associated with reduced risk of cardiovascular and kidney outcomes irrespective of background use of cardiovascular medications

The ABCD2 score: Risk of stroke after Transient Ischemic Attack (TIA) [Classics Series]

MRI enhances diagnostic certainty of ovarian cancer following indeterminate ultrasound [Classics Series]

#VisualAbstract: Addition of selumetinib to radioactive iodine does not improve remission rates in differentiated thyroid cancers

#VisualAbstract: Addition of selumetinib to radioactive iodine does not improve remission rates in differentiated thyroid cancers

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • SGLT2 inhibitors may delay cognitive impairment in elderly patients with heart failure
  • Nerandomilast slows decline in FVC in idiopathic pulmonary fibrosis
  • Mazdutide significantly reduces weight in adults with overweight or obesity
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.